title: Increased bleeding risk associated with the use of recombinant human activated protein C in patients with advanced liver disease.
authors.forename: Adam
authors.initials: A
authors.lastname: Keene
authors.forename: Thomas
authors.initials: T
authors.lastname: Kawano
authors.forename: Syed
authors.initials: S
authors.lastname: Anees
authors.forename: Julie
authors.initials: J
authors.lastname: Chen
mesh_terms: D018806:APACHE; D000925:Anticoagulants / Q000009:adverse effects*; D000075202:Contraindications; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D008107:Liver Diseases / Q000145:classification / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011486:Protein C / Q000009:adverse effects*; D011994:Recombinant Proteins / Q000009:adverse effects*; D012189:Retrospective Studies; D012306:Risk
chemical_list: D000925:Anticoagulants; D011486:Protein C; D011994:Recombinant Proteins